ISPC

SEC source: 0001104659-22-022558 · tm226491-3_5seq1.xml · nonDerivative · entry 6

Bielak Benjamin · CIK 0001857054 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,496

SEC source: 0001104659-22-022558 · tm226491-3_5seq1.xml · nonDerivative · entry 5

Bielak Benjamin · CIK 0001857054 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,214

SEC source: 0001104659-21-140720 · tm2133335-1_4seq1.xml · nonDerivative · entry 2

Curley Tracy · CIK 0001857028 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

SEC source: 0001104659-21-140720 · tm2133335-1_4seq1.xml · nonDerivative · entry 1

Curley Tracy · CIK 0001857028 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 7

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wingood Capital LLC

Disclosed balance after: 1,314,524

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 6

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,313,524

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 5

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,313,024

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 4

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,312,524

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 3

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wingood Capital LLC

Disclosed balance after: 1,312,024

SEC source: 0001104659-22-022558 · tm226491-3_5seq1.xml · nonDerivative · entry 4

Bielak Benjamin · CIK 0001857054 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,749

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · derivative · entry 9

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

F2 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.

F3 · price: The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.

F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · derivative · entry 8

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,525

Underlying: Common Stock · 13,525 shares

Expires not disclosed

F1 · security: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F1 · derivative.exercise_price: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F3 · price: The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company.

F1 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F1 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

SEC source: 0001104659-22-022553 · tm226491-2_5seq1.xml · derivative · entry 2

Brooks John L · CIK 0001343930 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,525

Underlying: Common Stock · 13,525 shares

Expires not disclosed

F3 · security: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F4 · price: The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company.

F3 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F3 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

SEC source: 0001104659-22-022553 · tm226491-2_5seq1.xml · nonDerivative · entry 1

Brooks John L · CIK 0001343930 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

SEC source: 0001104659-22-022576 · tm226491-8_5seq1.xml · derivative · entry 2

Scholl George H. · CIK 0001857026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,525

Underlying: Common Stock · 13,525 shares

Expires not disclosed

F3 · security: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F4 · price: The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company.

F3 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F3 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

SEC source: 0001104659-22-022576 · tm226491-8_5seq1.xml · nonDerivative · entry 1

Scholl George H. · CIK 0001857026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · security: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F1 · shares: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company.

F1 · balance_after: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

SEC source: 0001104659-22-022568 · tm226491-6_5seq1.xml · derivative · entry 2

Gullans Steven R. Ph.D. · CIK 0001571997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,525

Underlying: Common Stock · 13,525 shares

Expires not disclosed

F3 · security: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F4 · price: The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company.

F3 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F3 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

SEC source: 0001104659-22-022568 · tm226491-6_5seq1.xml · nonDerivative · entry 1

Gullans Steven R. Ph.D. · CIK 0001571997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

SEC source: 0001104659-22-022560 · tm226491-4_5seq1.xml · nonDerivative · entry 1

Ianelli Christopher · CIK 0001857027 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 395,441

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as an officer of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

SEC source: 0001104659-22-022572 · tm226491-7_5seq1.xml · derivative · entry 2

Lawrence Margaret H. · CIK 0001857015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,525

Underlying: Common Stock · 13,525 shares

Expires not disclosed

F3 · security: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F4 · price: The NSOs were awarded as compensation to the Reporting Person for her service as a director of the Company.

F3 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

F3 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock upon exercise subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.

SEC source: 0001104659-22-022572 · tm226491-7_5seq1.xml · nonDerivative · entry 1

Lawrence Margaret H. · CIK 0001857015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · security: Represents shares underlying certain restricted stock units ("RSUs") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for her service as the director of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs") each of which represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on June 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock.

SEC source: 0001104659-22-022565 · tm226491-5_5seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,547

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for her service as an officer of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

SEC source: 0001104659-22-022558 · tm226491-3_5seq1.xml · nonDerivative · entry 3

Bielak Benjamin · CIK 0001857054 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,467

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement "). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June21, 2023, June 21, 2024 and June 21,2025, Subject to the terms and conditions set forth in the RSU Agreement. 9,469 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 9,469 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as an officer of the Company.

SEC source: 0001104659-22-022544 · tm226491-1_5seq1.xml · nonDerivative · entry 1

Curley Tracy · CIK 0001857028 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,879

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for her service as an officer of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 7,575 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 7,575 shares of common stock.

SEC source: 0001104659-22-022558 · tm226491-3_5seq1.xml · nonDerivative · entry 2

Bielak Benjamin · CIK 0001857054 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,118

SEC source: 0001104659-21-144593 · tm2134159-1_4seq.xml · nonDerivative · entry 2

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,311,024

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 13

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Andrew L. Ross 2013 Irrevocable Trust

Disclosed balance after: 0

Underlying: Common Stock · 13,985 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

F9 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 12

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 86.438 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.

F8 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 11

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Andrew L. Ross 2013 Irrevocable Trust

Disclosed balance after: 13,985

Underlying: Common Stock · 39 shares

Expires 2021-06-30

F9 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

F11 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note.

F9 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

F9 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 10

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,438

Underlying: Common Stock · 2,420 shares

Expires 2021-06-30

F8 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.

F11 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note.

F8 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.

F8 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 9

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 360,674 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.

F7 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 8

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,674

Underlying: Common Stock · 231 shares

Expires 2021-06-30

F7 · derivative.exercise_price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.

F10 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note.

F7 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.

F7 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 7

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 130,081 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date.

F6 · price: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date.

F6 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date.

F6 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · derivative · entry 6

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 355,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F5 · price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F5 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F5 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · nonDerivative · entry 5

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Andrew L. Ross 2013 Irrevocable Trust

Disclosed balance after: 1,310,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

F4 · price: Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · nonDerivative · entry 4

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,296,539

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

F4 · price: Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · nonDerivative · entry 3

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,210,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person.

F3 · price: Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · nonDerivative · entry 2

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 849,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion.

F2 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion.

SEC source: 0001104659-21-084775 · tm2120463-1_4seq1.xml · nonDerivative · entry 1

Ross Andrew L. · CIK 0001857013 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 719,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

F1 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 5

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,897 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F4 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 4

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,897

Underlying: Common Stock · 255 shares

Expires 2021-06-30

F4 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F5 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note.

F4 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F4 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 3

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · nonDerivative · entry 2

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

F2 · price: Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

F1 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

SEC source: 0001104659-21-084750 · tm2120463-2_4seq1.xml · derivative · entry 2

Ianelli Christopher · CIK 0001857027 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date.

F2 · price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date.

F2 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date.

F2 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering and has no expiration date.

SEC source: 0001104659-21-084750 · tm2120463-2_4seq1.xml · nonDerivative · entry 1

Ianelli Christopher · CIK 0001857027 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,357

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

F1 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

SEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 8

OBF Investments, LLC · CIK 0001857012 · 10% owner

Scholl George H. · CIK 0001857026 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 119,035 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO.

F7 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 7

OBF Investments, LLC · CIK 0001857012 · 10% owner

Scholl George H. · CIK 0001857026 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,035

Underlying: Common Stock · 364 shares

Expires 2021-06-30

F7 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO.

F9 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note

F7 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO.

F7 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 6

OBF Investments, LLC · CIK 0001857012 · 10% owner

Scholl George H. · CIK 0001857026 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 472,490 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO.

F6 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO.

SEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 5

OBF Investments, LLC · CIK 0001857012 · 10% owner

Scholl George H. · CIK 0001857026 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,490

Underlying: Common Stock · 307 shares

Expires 2021-06-30

F6 · derivative.exercise_price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO.

F8 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note.

F6 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO.

F6 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO.